Chow Philip I, Showalter Shayna L, Gerber Matthew, Kennedy Erin M, Brenin David, Mohr David C, Lattie Emily G, Gupta Alisha, Ocker Gabrielle, Cohn Wendy F
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, United States.
Department of Surgery, University of Virginia, Charlottesville, VA, United States.
JMIR Cancer. 2020 Apr 15;6(1):e16476. doi: 10.2196/16476.
Nearly half of the patients with breast cancer experience clinically significant mental distress within the first year of receiving their cancer diagnosis. There is an urgent need to identify scalable and cost-efficient ways of delivering empirically supported mental health interventions to patients with breast cancer.
The aim of this study was to evaluate the feasibility of in-clinic recruitment for a mobile phone app study and to evaluate the usability and preliminary impact of a suite of mental health apps (IntelliCare) with phone coaching on psychosocial distress symptoms in patients recently diagnosed with breast cancer.
This pilot study adopted a within-subject, 7-week pre-post study design. A total of 40 patients with breast cancer were recruited at a US National Cancer Institute-designated clinical cancer center. Self-reported distress (Patient Health Questionnaire-4) and mood symptoms (Patient-Reported Outcomes Measurement Information System depression and anxiety scales) were assessed at baseline and postintervention. App usability was assessed at postintervention.
The minimum recruitment threshold was met. There was a significant decrease in general distress symptoms, as well as symptoms of depression and anxiety, from baseline to postintervention. Overall, participants reported high levels of ease of app use and learning. Scores for app usefulness and satisfaction were reinforced by some qualitative feedback suggesting that tailoring the apps more for patients with breast cancer could enhance engagement.
There is a dire need for scalable, supportive interventions in cancer. The results from this study inform how scalable mobile phone-delivered programs with additional phone support can be used to support patients with breast cancer.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/11452.
近一半的乳腺癌患者在确诊后的第一年经历临床上显著的心理困扰。迫切需要找到可扩展且具有成本效益的方法，为乳腺癌患者提供经验证有效的心理健康干预措施。
本研究旨在评估在诊所招募患者参与手机应用程序研究的可行性，并评估一套心理健康应用程序（智能关怀）及电话辅导对近期确诊乳腺癌患者心理社会困扰症状的可用性和初步影响。
这项试点研究采用了受试者内7周前后对照的研究设计。在美国国立癌症研究所指定的临床癌症中心招募了40名乳腺癌患者。在基线和干预后评估自我报告的困扰（患者健康问卷-4）和情绪症状（患者报告结局测量信息系统抑郁和焦虑量表）。在干预后评估应用程序的可用性。
达到了最低招募阈值。从基线到干预后，一般困扰症状以及抑郁和焦虑症状均显著下降。总体而言，参与者报告应用程序使用和学习的难易程度较高。应用程序有用性和满意度得分得到了一些定性反馈的加强，这些反馈表明，更针对乳腺癌患者定制应用程序可以提高参与度。
癌症患者迫切需要可扩展的支持性干预措施。本研究结果为如何利用可扩展的手机应用程序及额外的电话支持来帮助乳腺癌患者提供了参考。
国际注册报告识别码（IRRID）：RR2-10.2196/11452 。
